265 Pill - purple capsule/oblong, 18mm
Pill with imprint 265 is Purple, Capsule/Oblong and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Ascend Laboratories LLC.
Mycophenolate mofetil is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 265
Mycophenolate Mofetil
- Imprint
- 265
- Strength
- 500 mg
- Color
- Purple
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ascend Laboratories LLC
- National Drug Code (NDC)
- 67877-0225
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone,
microcrystalline cellulose,
hypromelloses,
polyethylene glycol,
isopropyl alcohol,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "265"
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.